Library · Due Diligence

Patent Ownership During Equity Rounds: What Investors Check and Why It Stalls Deals

When investors conduct IP due diligence before closing an equity round, patent ownership gaps are among the most common deal-killers — here is what they look for and how to get ahead of it

2026-11-16 · due diligence · patent ownership · equity rounds · assignment

Equity investors — from seed-stage angels to late-stage venture funds — routinely ask for IP documentation before wiring money. If your startup holds patents or pending applications, those assets will be examined, and the question every investor is really asking is the same: does the company actually own what it says it owns? Gaps in the answer do not just slow a deal; they can reprice it, trigger escrow holdbacks, or kill the round entirely.

What Investors Are Actually Checking

Ownership of a patent is a legal conclusion, not just a name on a cover sheet. The USPTO lists inventors, not owners, on the face of a granted patent. Ownership flows from assignment — a written transfer of rights from the inventor to the company. Investors will want to see that every named inventor has executed a valid assignment to the entity raising money.

This sounds mechanical, but it breaks down in practice for predictable reasons:

The Assignment Chain Problem

Investors performing IP due diligence will often trace the full assignment chain — every link between the original inventors and the current company. A missing link anywhere in that chain is a defect. The practical problem is that gaps are easy to create and surprisingly hard to fix after the fact.

When a co-founder has left the company before the round, tracking them down to execute a corrective assignment can be slow, expensive, and occasionally impossible if the relationship ended badly. When a contractor is located overseas or no longer reachable, the company may have no clean path to a valid assignment without litigation risk. These are not hypothetical edge cases; they come up regularly in due diligence.

One specific issue worth flagging: an assignment that covers "all inventions" related to the business but was signed before the patent application was filed may or may not automatically cover that application, depending on how it was drafted. Investors will want to see assignments that specifically reference the application by serial number or at minimum cover all applications in the relevant field.

Encumbrances Investors Also Look For

Ownership is not the only concern. Even a cleanly assigned patent can carry encumbrances that reduce its value or restrict how the company can use it:

Prior Licenses

If a patent was licensed to a third party before the round — including through an open source project with patent retaliation clauses, a research institution collaboration, or an earlier commercial arrangement — investors will want to understand the scope of that license and whether it limits the company's ability to enforce or monetize the patent.

Government Funding

If federal funding contributed to the invention, the Bayh-Dole Act gives the government a license to use the invention and imposes obligations on the company, including domestic manufacturing preferences and reporting requirements. Investors in deep tech and research-adjacent startups specifically ask about this.

Security Interests

Patents can be pledged as collateral. A lender who holds a security interest in the patent portfolio will have priority over investors if the company defaults. Investors will search the USPTO assignment database and the UCC filings in the company's state of formation to identify any recorded security interests.

Practical Takeaways

Draft it, search it, check it — with a human in the loop.

YourPatentAI drafts provisional and non-provisional applications, runs prior-art search with IDS export, and checks claims for §§ 102, 103 and 112 issues before you file.

Get YourPatentAILearn more

This guide is general education, not legal advice, and does not create an attorney–client relationship. For your specific situation, talk to a registered patent attorney.